NL7301975A - - Google Patents

Info

Publication number
NL7301975A
NL7301975A NL7301975A NL7301975A NL7301975A NL 7301975 A NL7301975 A NL 7301975A NL 7301975 A NL7301975 A NL 7301975A NL 7301975 A NL7301975 A NL 7301975A NL 7301975 A NL7301975 A NL 7301975A
Authority
NL
Netherlands
Application number
NL7301975A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7301975A publication Critical patent/NL7301975A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL7301975A 1972-02-11 1973-02-12 NL7301975A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207420A DE2207420A1 (de) 1972-02-11 1972-02-11 Verfahren zur herstellung von 16,17ungesaettigten steroiden

Publications (1)

Publication Number Publication Date
NL7301975A true NL7301975A (cg-RX-API-DMAC10.html) 1973-08-14

Family

ID=5836210

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7301975A NL7301975A (cg-RX-API-DMAC10.html) 1972-02-11 1973-02-12

Country Status (15)

Country Link
US (1) US3842105A (cg-RX-API-DMAC10.html)
JP (1) JPS4886854A (cg-RX-API-DMAC10.html)
AT (1) AT328102B (cg-RX-API-DMAC10.html)
AU (1) AU468856B2 (cg-RX-API-DMAC10.html)
BE (1) BE795243A (cg-RX-API-DMAC10.html)
CH (1) CH586719A5 (cg-RX-API-DMAC10.html)
CS (1) CS165381B2 (cg-RX-API-DMAC10.html)
DD (1) DD100942A5 (cg-RX-API-DMAC10.html)
DE (1) DE2207420A1 (cg-RX-API-DMAC10.html)
DK (1) DK131942C (cg-RX-API-DMAC10.html)
FR (1) FR2171374B1 (cg-RX-API-DMAC10.html)
GB (1) GB1424212A (cg-RX-API-DMAC10.html)
HU (1) HU165442B (cg-RX-API-DMAC10.html)
NL (1) NL7301975A (cg-RX-API-DMAC10.html)
SE (1) SE385591B (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216159A (en) * 1978-05-25 1980-08-05 The Upjohn Company Synthesis of 16-unsaturated pregnanes from 17-keto steroids
US5169966A (en) * 1987-09-11 1992-12-08 Nippon Zeon Co., Ltd Process for producing an α-acyloxy-α, β-unsaturated carbonyl compound and a 20-acyloxy-17(20)-methylen-21-al-steroid compound
EP0306969B1 (en) * 1987-09-11 1994-11-30 Nippon Zeon Co., Ltd. A process for producing an alpha-acyloxy-alpha beta-unsaturated carbonyl compound and a 20-acyl-oxy-17(20)-methylen-21-al-steroid compound
EP3656385A1 (en) 2008-05-28 2020-05-27 ReveraGen BioPharma, Inc. Non-hormonal steroid modulators of nf-kb for treatment of disease
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
CN102603843B (zh) * 2012-02-20 2013-07-31 湖南诺凯生物医药有限公司 一种地塞米松中间体的制备方法
WO2017004205A1 (en) 2015-06-29 2017-01-05 Reveragen Biopharma, Inc. NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Also Published As

Publication number Publication date
HU165442B (cg-RX-API-DMAC10.html) 1974-08-28
GB1424212A (en) 1976-02-11
CS165381B2 (cg-RX-API-DMAC10.html) 1975-12-22
AT328102B (de) 1976-03-10
CH586719A5 (cg-RX-API-DMAC10.html) 1977-04-15
AU468856B2 (en) 1976-01-22
DK131942C (da) 1976-02-23
AU5193173A (en) 1974-08-08
DE2207420A1 (de) 1973-08-16
FR2171374A1 (cg-RX-API-DMAC10.html) 1973-09-21
US3842105A (en) 1974-10-15
FR2171374B1 (cg-RX-API-DMAC10.html) 1976-06-11
BE795243A (fr) 1973-08-09
DD100942A5 (cg-RX-API-DMAC10.html) 1973-10-12
ATA112373A (de) 1975-05-15
DK131942B (da) 1975-09-29
JPS4886854A (cg-RX-API-DMAC10.html) 1973-11-15
SE385591B (sv) 1976-07-12

Similar Documents

Publication Publication Date Title
FR2184041A1 (cg-RX-API-DMAC10.html)
FR2171374B1 (cg-RX-API-DMAC10.html)
JPS4939935U (cg-RX-API-DMAC10.html)
FR2178082A1 (cg-RX-API-DMAC10.html)
JPS5533420B2 (cg-RX-API-DMAC10.html)
JPS5210194B2 (cg-RX-API-DMAC10.html)
JPS4954657A (cg-RX-API-DMAC10.html)
JPS5717333B2 (cg-RX-API-DMAC10.html)
JPS4982097A (cg-RX-API-DMAC10.html)
JPS4981448U (cg-RX-API-DMAC10.html)
CS152409B2 (cg-RX-API-DMAC10.html)
CS156055B1 (cg-RX-API-DMAC10.html)
CS157348B1 (cg-RX-API-DMAC10.html)
CS161327B1 (cg-RX-API-DMAC10.html)
IN137999B (cg-RX-API-DMAC10.html)
JPS48104232U (cg-RX-API-DMAC10.html)
JPS48109186U (cg-RX-API-DMAC10.html)
CS161348B1 (cg-RX-API-DMAC10.html)
JPS4882427U (cg-RX-API-DMAC10.html)
CH1125573A4 (cg-RX-API-DMAC10.html)
CH561361A5 (cg-RX-API-DMAC10.html)
BG18786A1 (cg-RX-API-DMAC10.html)
BG19261A1 (cg-RX-API-DMAC10.html)
BG19449A1 (cg-RX-API-DMAC10.html)
CH577098A5 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
BV The patent application has lapsed